Back to search

Georgia Institute of Technology

Design and Characterization of Modified Lytic Enzymes and Nanoparticle-Based Vaccines to Combat S. aureus

Abstract

dc:description.abstract

There is an imminent threat posed by the expanding list of “superbugs” or antibiotic-resistant bacteria that cause life-threatening infections. Methicillin-Resistant Staphylococcus aureus (MRSA) is one such superbug that is easily spread in hospitals and within communities. Many therapeutics fail to adequately treat infections caused by MRSA, leaving clinicians and patients with few options such as last resort antibiotics. The rapid pace of evolution of antimicrobial resistance to new and last resort antibiotics necessitates research and development of viable alternative strategies for preventing and treating infections. Our approach for tackling this growing public health concern involves three aims: incorporation of reactive handles into lytic enzymes, modification of lytic enzymes to reduce their immunogenicity, and designing vaccines that elicit broadly protective antibodies against S. aureus. First, lytic enzymes such as lysostaphin are modular antimicrobials that could potentially constitute a viable source for antimicrobial agents that are active against antibiotic-resistant bacteria. Engineering these enzymes with reactive moieties can greatly broaden their potential applications to include incorporation in wound-healing biomaterials. Second, the efficacy of lytic enzymes in vivo is stymied by its low in vivo half-life and the potential to elicit an immune response. We offer two different approaches for reducing the immunogenicity of lytic enzymes: using site-specific pegylation or using site-specific glycosylation. Third, S. aureus has an arsenal of toxins and mechanisms that facilitate evasion of the host immune system. A vaccine that can elicit broad protection to multiple S. aureus toxins is needed to reduce infections and disease severity. We aim to design and characterize a protein-based vaccine against S. aureus that can elicit antibodies that can neutralize multiple members of a family of S. aureus toxins.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Materials Science and Engineering
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Batugal, Troy Guzman
Advisors dc:contributor.advisor
  • Kalkanci, Basak
  • Kane, Ravi S.
Committee members dc:contributor.committeemember
  • Garcia, Andres J.
  • Wilson, Corey J.
  • Champion, Julie
  • Brettmann, Blair

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1853/72577

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Batugal, Troy Guzman. Design and Characterization of Modified Lytic Enzymes and Nanoparticle-Based Vaccines to Combat S. aureus. Doctoral thesis, Georgia Institute of Technology, 2022. https://hdl.handle.net/1853/72577